Form 4: Bio-Rad Laboratories Executive Receives Stock Grant
Insider Transaction (Form 4)
Rajat Mehta, EVP, GBL Commercial Operations of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Option exercise/conversion: acquired 456 Bio-Rad A Common Stock on September 5, 2026; holds 599 after (Direct).
- Tax/exercise-price withholding: disposed of 233 Bio-Rad A Common Stock at $386.11 ($89,964) on September 5, 2026; holds 366 after (Direct).
- Option exercise/conversion: acquired 1,370 Bio-Rad A Common Stock on September 5, 2026; holds 1,736 after (Direct).
- Tax/exercise-price withholding: disposed of 504 Bio-Rad A Common Stock at $386.11 ($194,599) on September 5, 2026; holds 1,232 after (Direct).
- Grant/award: acquired 4,601 Restricted Stock Units on September 4, 2026; holds 4,601 after (Direct).
- Option exercise/conversion: disposed of 456 Restricted Stock Units on September 5, 2026; holds 1,371 after (Direct).
- Option exercise/conversion: disposed of 1,370 Restricted Stock Units on September 5, 2026; holds 4,110 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Rajat Mehta — Officer (EVP, GBL Commercial Operations)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 456 | — | — | 599.052 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 233 | $386 | $90.0K | 366.052 |
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 1,370 | — | — | 1,736.052 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 504 | $386 | $194.6K | 1,232.052 |
| 2026-09-04 | Grant/award | Restricted Stock Units | 4,601 | — | — | 4,601 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 456 | — | — | 1,371 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 1,370 | — | — | 4,110 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Option exercise/conversion (456 shares) |
| 2026-09-05 | Tax/exercise-price withholding (233 shares) |
| 2026-09-05 | Option exercise/conversion (1,370 shares) |
| 2026-09-05 | Tax/exercise-price withholding (504 shares) |
| 2026-09-04 | Grant/award (4,601 shares) |
| 2026-09-05 | Option exercise/conversion (456 shares) |
| 2026-09-05 | Option exercise/conversion (1,370 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Rajat Mehta
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.